Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone

Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone - Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071180084

Enrollment

100

Registered

2019-03-29

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High risk for preterm birth

Interventions

Administration of vaginal progesterone capsule (200mg/dl) once daily between 16 and 34 weeks of gestations

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: women with prior preterm birth after second trimester

Exclusion criteria

Exclusion criteria: 1)prior preterm birth by induction for obstetrics complication 2)contraindication of progesterone 3)multiple pregnancy 4)fetus of severe anomaly or abnormal chromosome

Design outcomes

Primary

Measure	Time frame
Rate of preterm birth	—

Secondary

Measure	Time frame
NICU admission period, neonatal complications, rate of threatened preterm birth, rate of premature rupture of membrane, Fetal death, maternal adverse event	—

Contacts

Public ContactYasuyuki Fujita

Kyushu university hospital

fujita.yasuyuki.889@m.kyushu-u.ac.jp+81-92-642-5395

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026